Provided by Tiger Trade Technology Pte. Ltd.

First Advantage Corp.

20.90
-0.3300-1.55%
Post-market: 20.900.00000.00%16:10 EDT
Volume:1.56M
Turnover:32.77M
Market Cap:3.59B
PE:143.92
High:21.36
Open:21.28
Low:20.74
Close:21.23
52wk High:25.15
52wk Low:8.82
Shares:171.54M
Float Shares:93.74M
Volume Ratio:0.76
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1452
EPS(LYR):-0.2011
ROE:1.94%
ROA:2.82%
PB:2.77
PE(LYR):-103.95

Loading ...

First Advantage Is Maintained at Overweight by Barclays

Dow Jones
·
May 08

First Advantage to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 08

Analysts Offer Insights on Industrial Goods Companies: Axon Enterprise (AXON), First Advantage (FA) and Kennametal (KMT)

TIPRANKS
·
May 08

Analysts’ Top Industrial Goods Picks: The Middleby (MIDD), First Advantage (FA)

TIPRANKS
·
May 08

Voyager Reports First Quarter 2026 Financial and Operating Results

GlobeNewswire
·
May 08

Analysts Conflicted on These Industrial Goods Names: Global Payments (GPN), First Advantage (FA) and BWX Technologies (BWXT)

TIPRANKS
·
May 07

First Advantage Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

GUIDANCE: (FA) First Advantage Expects 2026 Adjusted EPS Range $1.15 - $1.25, vs. FactSet Est of $1.20

MT Newswires Live
·
May 07

First Advantage Q1 Adj. EPS $0.26 Beats $0.21 Estimate, Sales $385.200M Beat $372.602M Estimate

Benzinga Earnings
·
May 07

BRIEF-First Advantage Q1 Revenue USD 385.2 Million Vs. IBES Estimate USD 372.6 Million

Reuters
·
May 07

First Advantage Corp - Reaffirms Full Year 2026 Guidance

THOMSON REUTERS
·
May 07

First Advantage Q1 Cash Flow From Operations USD 49.4 Million

THOMSON REUTERS
·
May 07

First Advantage Reports First Quarter 2026 Results

GlobeNewswire
·
May 07

First Advantage files Form 3 as director Mark Gillett reports 10,000 shares

Reuters
·
May 05

Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia

GlobeNewswire
·
May 01

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

GlobeNewswire
·
Apr 30

Earning Preview: First Advantage Corp. Q1 revenue expected to increase by 8.21%, and institutional views are cautiously constructive

Earnings Agent
·
Apr 30

Press Release: Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates

Dow Jones
·
Apr 29

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

GlobeNewswire
·
Apr 28

First Advantage announces annual shareholder meeting

Reuters
·
Apr 25